Fabbrocini G - Search Results

1

Autoimmune Skin Diseases and Immune Checkpoint Inhibitors.

Fattore D, Potestio L, Genco L, Pages C, Ortiz A, Fabbrocini G, Sibaud V. Fattore D, et al. Among authors: fabbrocini g. Crit Rev Immunol. 2022;42(3):11-22. doi: 10.1615/CritRevImmunol.2023047032. Crit Rev Immunol. 2022. PMID: 37017623 Review.

2

Bullous pemphigoid and nivolumab: Dermatologic management to support and continue oncologic therapy.

Panariello L, Fattore D, Annunziata MC, Piantedosi F, Gilli M, Fabbrocini G. Panariello L, et al. Among authors: fabbrocini g. Eur J Cancer. 2018 Nov;103:284-286. doi: 10.1016/j.ejca.2018.08.022. Epub 2018 Sep 26. Eur J Cancer. 2018. PMID: 30268391 No abstract available.

3

Combination of permethrin 5% cream with liquid cleanser containing Chlorhexidine, agents from Szechuan peppers, menthol and camphor in scabies treatment.

Greco V, Fattore D, Annunziata MC, Fabbrocini G. Greco V, et al. Among authors: fabbrocini g. G Ital Dermatol Venereol. 2019 Oct;154(5):607-608. doi: 10.23736/S0392-0488.18.06079-0. Epub 2018 Oct 3. G Ital Dermatol Venereol. 2019. PMID: 30295443 No abstract available.

4

Prurigo nodularis and pembrolizumab: A therapeutic challenge.

Fattore D, Panariello L, Annunziata MC, Fabbrocini G. Fattore D, et al. Among authors: fabbrocini g. Eur J Cancer. 2019 Mar;110:8-10. doi: 10.1016/j.ejca.2019.01.012. Epub 2019 Feb 5. Eur J Cancer. 2019. PMID: 30735833 No abstract available.

5

Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast.

Fattore D, Annunziata MC, Panariello L, Marasca C, Fabbrocini G. Fattore D, et al. Among authors: fabbrocini g. Eur J Cancer. 2019 Mar;110:107-109. doi: 10.1016/j.ejca.2019.01.010. Epub 2019 Feb 18. Eur J Cancer. 2019. PMID: 30785013 No abstract available.

6

Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia.

Freites-Martinez A, Chan D, Sibaud V, Shapiro J, Fabbrocini G, Tosti A, Cho J, Goldfarb S, Modi S, Gajria D, Norton L, Paus R, Cigler T, Lacouture ME. Freites-Martinez A, et al. Among authors: fabbrocini g. JAMA Dermatol. 2019 Jun 1;155(6):724-728. doi: 10.1001/jamadermatol.2018.5071. JAMA Dermatol. 2019. PMID: 30840033 Free PMC article.

7

Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes".

Marasca C, Masarà A, Annunziata MC, Fattore D, Fabbrocini G. Marasca C, et al. Among authors: fabbrocini g. J Am Acad Dermatol. 2023 May;88(5):e269. doi: 10.1016/j.jaad.2019.02.066. Epub 2019 Mar 11. J Am Acad Dermatol. 2023. PMID: 30872151 No abstract available.

8

Allergic Contact Dermatitis Probably Due to Naftifine Hydrochloride.

Napolitano M, Fattore D, Fabbrocini G, Patruno C. Napolitano M, et al. Among authors: fabbrocini g. Dermatitis. 2019 May/Jun;30(3):231-233. doi: 10.1097/DER.0000000000000462. Dermatitis. 2019. PMID: 31045930 No abstract available.

9

Legal, medical, and ethical implications of instant messaging application use in dermatology.

Fattore D, Delfino M, Fabbrocini G. Fattore D, et al. Among authors: fabbrocini g. Int J Dermatol. 2019 Oct;58(10):e206-e207. doi: 10.1111/ijd.14519. Epub 2019 Jun 7. Int J Dermatol. 2019. PMID: 31173337 No abstract available.

10

Pyogenic granuloma-like lesions: a novel side effect of capecitabine.

Panariello L, Fattore D, Cantelli M, Fabbrocini G. Panariello L, et al. Among authors: fabbrocini g. Ital J Dermatol Venerol. 2021 Dec;156(Suppl. 1 to No. 6):60-61. doi: 10.23736/S2784-8671.19.06359-4. Epub 2019 Jul 26. Ital J Dermatol Venerol. 2021. PMID: 31355617 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

773 results

Search Page

Filters